USPTO serial 85807324
X-MAN
Reviewed by CopyMark Law Group
Reg. 4586798Status 710
- Filing date
- Status date
- Registration date
- Aug 19, 2014
- Examiner
- KUYKENDALL, LYNDSEY
- Law office
- POST REGISTRATION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with X-MAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Waterbeach, Cambridge, GB
Waterbeach, Cambridge, GB
Waterbeach, Cambridge, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark B. Harrison
MARK B. HARRISON VENABLE LLPP.O. Box 34385WASHINGTON, DC 20043UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; Molecular biology research tools, in the nature of biological and biochemical reagents, specifically, genomic DNA; DNA repair enzymes for scientific and research purposes; Biological and chemical reagents, namely, genomic DNA, cell cultures and mutant and normal isogenic human cell line pairs, for research use | SECTION 8 - CANCELLED | — |
| 005 | Protein cell lysates. genomic DNA preparations and formalin fixed, paraffin embedded (FFPE) engineered tumor tissue mimics for medical diagnostic use | SECTION 8 - CANCELLED | — |
| 042 | Custom cell-line engineering services; Scientific research in the field of genetics and genetic engineering, namely, gene-editing services, DNA modeling services, gene engineering services, establishing patient genotypes; Bio-technology, pharmaceutical and scientific testing, research and development services relating to genetics, and providing advice, consultancy and information services related thereto; biological research; pharmaceutical research services; drug discovery services; Scientific research and development services for lead identification and validation; Scientific research and development services for target identification and validation; Pharmaceutical research, namely, identification of patient-relevant drug targets, optimization of drug candidates for clinical development; Laboratory diagnostic services, namely, diagnosis of genetic mutations for clinical or research purposes and the design of molecular reference standards for assay development, clinical diagnostic quality control and proficiency schemes for the medical diagnostic services industry; medicinal research services, namely, hit discovery and hit to lead services; research and development services in the nature of creating libraries and collections of cells and cell lines, chemicals and compounds; research and development services in the nature of creating libraries and collections of normal and mutated genes; Scientific research and development services relating to targeting therapies to individuals; Scientific research and development services relating to combining therapies for individuals; research and development relating to reagents; Scientific research in the field of disease modeling; Medical and scientific research, namely, designing and conducting clinical trials for others; research and development in re-positioning existing drugs from other therapeutic indications | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Horizon Discovery Limited
- Other trademarks owned by Horizon Discovery Limited
- Other trademarks owned by Horizon Discovery Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named X-MAN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 26, 2021 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 19, 2019 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 21, 2017 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 21, 2017 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 19, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 19, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 18, 2014 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 15, 2014 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 8, 2014 | AMD7 | SEC 7 REQUEST FILED | — |
| Sep 8, 2014 | PAPER RECEIVED | — | |
| Aug 19, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 3, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 14, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 28, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 25, 2014 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Apr 25, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 25, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 25, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 25, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 25, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 24, 2014 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Apr 24, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2014 | PAPER RECEIVED | — | |
| Nov 4, 2013 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2013 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Oct 17, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 2013 | PAPER RECEIVED | — | |
| Apr 11, 2013 | CEPE | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | — |
| Apr 11, 2013 | CEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED | — |
| Apr 11, 2013 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Apr 8, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 21, 2013 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Feb 21, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 13, 2013 | ALIE | ASSIGNED TO LIE | — |
| Feb 8, 2013 | PAPER RECEIVED | — | |
| Jan 9, 2013 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Jan 8, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 24, 2012 | NWAP | NEW APPLICATION ENTERED | — |